Open AccessAdvanced glycation end products, a potential link between psoriasis and cardiovascular disease: A case–control study
Author(s) -
Tülin Ergun,
Vildan Yazici,
Dilek Yavuz,
Dilek Seckin-Gencosmanoglu,
Gülşen Özen,
Andaç Salman,
Haner Direşkeneli,
Nevsun İnanç
Publication year - 2019
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_396_18
Subject(s) - medicine , psoriasis , glycation , inflammation , context (archaeology) , mann–whitney u test , disease , gastroenterology , premature aging , systemic inflammation , diabetes mellitus , cardiology , endocrinology , dermatology , physiology , paleontology , biology
Advanced glycation end products (AGEs) promote oxidative stress and inflammation by altering structure and function of proteins. They are excessively produced mainly in hyperglycemia, chronic inflammation and are involved in the development of atherosclerosis and cardiovascular disease.